L.E. Seargeant

1.0k total citations
30 papers, 812 citations indexed

About

L.E. Seargeant is a scholar working on Molecular Biology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L.E. Seargeant has authored 30 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L.E. Seargeant's work include Metabolism and Genetic Disorders (10 papers), Alkaline Phosphatase Research Studies (8 papers) and Biochemical and Molecular Research (4 papers). L.E. Seargeant is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Alkaline Phosphatase Research Studies (8 papers) and Biochemical and Molecular Research (4 papers). L.E. Seargeant collaborates with scholars based in Canada, United States and Netherlands. L.E. Seargeant's co-authors include Robert A. Stinson, Cheryl R. Greenberg, J. C. Haworth, Louise A. Dilling, Frances Booth, B.N. Chodirker, R. J. A. Wanders, Oscar Casiro, Jos P.N. Ruiter and Albert E. Chudley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Biochemical Journal.

In The Last Decade

L.E. Seargeant

30 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.E. Seargeant Canada 15 403 299 243 167 117 30 812
Rob Barto Netherlands 15 156 0.4× 216 0.7× 134 0.6× 50 0.3× 71 0.6× 35 643
J. Schaub Germany 20 228 0.6× 173 0.6× 73 0.3× 284 1.7× 124 1.1× 57 1.0k
Hiroki Tsuchida Japan 17 336 0.8× 147 0.5× 145 0.6× 45 0.3× 66 0.6× 47 923
Jürgen Schaub Germany 10 300 0.7× 69 0.2× 255 1.0× 199 1.2× 86 0.7× 26 838
D. C. Cusworth United Kingdom 15 251 0.6× 469 1.6× 59 0.2× 398 2.4× 183 1.6× 25 994
Bridget Wilcken Australia 18 487 1.2× 623 2.1× 54 0.2× 353 2.1× 258 2.2× 37 1.2k
N. A. J. Carson United Kingdom 13 272 0.7× 442 1.5× 55 0.2× 653 3.9× 143 1.2× 33 1.2k
Jitka Sokolová Czechia 17 316 0.8× 232 0.8× 28 0.1× 469 2.8× 91 0.8× 33 900
Yukiko Hasuike Japan 22 195 0.5× 149 0.5× 85 0.3× 78 0.5× 29 0.2× 61 1.3k
Alan W. Hodson United Kingdom 10 173 0.4× 57 0.2× 244 1.0× 35 0.2× 46 0.4× 32 550

Countries citing papers authored by L.E. Seargeant

Since Specialization
Citations

This map shows the geographic impact of L.E. Seargeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.E. Seargeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.E. Seargeant more than expected).

Fields of papers citing papers by L.E. Seargeant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.E. Seargeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.E. Seargeant. The network helps show where L.E. Seargeant may publish in the future.

Co-authorship network of co-authors of L.E. Seargeant

This figure shows the co-authorship network connecting the top 25 collaborators of L.E. Seargeant. A scholar is included among the top collaborators of L.E. Seargeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.E. Seargeant. L.E. Seargeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Cheryl R., et al.. (2015). A rare case of Niemann–Pick disease type C without neurological involvement in a 66-year-old patient. SHILAP Revista de lepidopterología. 3. 18–20. 11 indexed citations
2.
Greenberg, Cheryl R., Asuri N. Prasad, Louise A. Dilling, et al.. (2002). Outcome of the First 3-Years of a DNA-Based Neonatal Screening Program for Glutaric Acidemia Type 1 in Manitoba and Northwestern Ontario, Canada. Molecular Genetics and Metabolism. 75(1). 70–78. 64 indexed citations
3.
Innes, A. Micheil, L.E. Seargeant, Charles R. Roe, et al.. (2000). Hepatic Carnitine Palmitoyltransferase I Deficiency Presenting as Maternal Illness in Pregnancy. Pediatric Research. 47(1). 43–43. 99 indexed citations
4.
Chodirker, Bernard N., G. J. Williams, L.E. Seargeant, et al.. (1998). Familial Neuroblastoma. Journal of Pediatric Hematology/Oncology. 20(5). 489–493. 4 indexed citations
5.
Laitinen, Arja, Marja Hietala, James C. Haworth, et al.. (1997). Two novel mutations in a Canadian family with aspartylglucosaminuria and early outcome post bone marrow transplantation. Clinical Genetics. 51(3). 174–178. 9 indexed citations
6.
Pianosi, Paolo T., L.E. Seargeant, & J. C. Haworth. (1995). Blood lactate and pyruvate concentrations, and their ratio during exercise in healthy children: developmental perspective. European Journal of Applied Physiology. 71(6). 518–522. 13 indexed citations
7.
Seargeant, L.E., et al.. (1995). Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect. Clinical Biochemistry. 28(3). 324–324. 2 indexed citations
8.
9.
Haworth, J. C., Louise A. Dilling, R. Surtees, et al.. (1993). Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. American Journal of Medical Genetics. 45(5). 572–576. 46 indexed citations
10.
Seargeant, L.E., et al.. (1991). Primary oxaluria type 2 (l-glyceric aciduria): A rare cause of nephrolithiasis in children. The Journal of Pediatrics. 118(6). 912–914. 19 indexed citations
11.
Haworth, J. C., Frances Booth, Albert E. Chudley, et al.. (1991). Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. The Journal of Pediatrics. 118(1). 52–58. 99 indexed citations
12.
Greenberg, Cheryl R., et al.. (1989). Newborn Screening for Galactosemia: A New Method Used in Manitoba. PEDIATRICS. 84(2). 331–335. 12 indexed citations
13.
Booth, Frances, J. C. Haworth, Louise A. Dilling, et al.. (1989). Mitochondrial encephalomyopathy with associated aminoacidopathy in a male sibship. The Journal of Pediatrics. 115(1). 81–88. 3 indexed citations
14.
Thompson, Robert G., L.E. Seargeant, & Jeremy S.D. Winter. (1989). Screening for congenital adrenal hyperplasia: Distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens. The Journal of Pediatrics. 114(3). 400–404. 26 indexed citations
15.
Chodirker, B.N., Jane Evans, M. Lewis, et al.. (1987). Infantile hypophosphatasia—Linkage with the RH locus. Genomics. 1(3). 280–282. 22 indexed citations
16.
Christie, Nanette, et al.. (1985). A case of de novo trisomy 12p syndrome.. PubMed. 28(4). 235–8. 19 indexed citations
17.
Seargeant, L.E. & Robert A. Stinson. (1979). Phosphoester specificity of purified human liver alkaline phosphatase.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(7). 2000–7. 15 indexed citations
18.
Seargeant, L.E. & Robert A. Stinson. (1979). Phosphoester specificity of purified human liver alkaline phosphatase. Canadian Journal of Biochemistry. 57(7). 1000–1007. 13 indexed citations
19.
Seargeant, L.E. & Robert A. Stinson. (1979). Inhibition of human alkaline phosphatases by vanadate. Biochemical Journal. 181(1). 247–250. 95 indexed citations
20.
Seargeant, L.E., et al.. (1976). Affinity purification and some molecular properties of human liver alkaline phosphatase. Biochemical Journal. 155(3). 653–660. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026